Supplementary Tables: Effects of CYP2C19 LoF allele on MACE associated with clopidogrel in ACS patients undergoing PCI: Meta-analysis.docx
Supplementary Table 1. Research Question-Are acute coronary syndrome patients undergoing percutaneous coronary intervention carrying CYP2C19 loss-of-function alleles treated with clopidogrel at increased risk of major adverse cardiovascular events?
Supplementary Table 2A. Quality assessment of the included observational studies by NOS
Supplementary Table 2B. Assessment of quality of included RCTs by Jadad scale